FDA approves first pill to treat moderate-to-severe Crohn's disease
Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
May 19, 2023
0
92
Nucleic Acids, Nucleotides, and Nucleosides: News and Research on Thionucleosides
MeSH tree: D13.570.900
Disease control, safe medications critical to pregnancies for women with rheumatic disease
Pregnant women with active rheumatic disease carry a higher risk of adverse outcomes than the general population including hypertension, preeclampsia, higher cesarean section rate, small for gestational aged infants, preterm ...
Jul 18, 2022
0
101
